CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 89 enrolled
Drug / intervention
Mindfulness Based Stress Reduction +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01033851
NCT01033851Phase 4Completed

Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects

Massachusetts General Hospital·interventional·Posted Dec 17, 2009·Updated Jun 4, 2014

In Brief

A Phase 4 clinical trial evaluating Mindfulness Based Stress Reduction and Stress Management Education for Generalized Anxiety Disorder. Completed, enrolled 89 participants across 1 site.

Detailed Summary

Current therapies for Generalized Anxiety Disorder (GAD) have limited effectiveness. This study measures the efficacy of two different approaches to reducing anxiety and stress. One approach uses education, nutrition, exercise, and time management training, and another uses mindfulness meditation and yoga, which is taught as part of the Mindfulness-based stress reduction (MBSR) course, an 8-week manualized mindfulness intervention. We hypothesize that the two approaches will reduce anxiety in individuals with GAD in different ways. We will measure changes in stress hormones associated with these changes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 17, 2009
Enrollment StartMar 1, 2008
Primary CompletionJan 1, 2012
Study CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 16.5 years ago

Interventions

Mindfulness Based Stress Reductionbehavioral

8 week course

Stress Management Educationbehavioral

8 week course